Drug Interactions Pharmacolgoy Prof. R. K. Dixit
... Primarily due to displacement of one drug from its binding sites on plasma proteins by another drug. Drugs highly bound to plasma proteins that have a relatively small volume of distribution like oral anticoagulants, sulfonylureas, certain NSAIDs and anti-epileptics are particularly liable to displa ...
... Primarily due to displacement of one drug from its binding sites on plasma proteins by another drug. Drugs highly bound to plasma proteins that have a relatively small volume of distribution like oral anticoagulants, sulfonylureas, certain NSAIDs and anti-epileptics are particularly liable to displa ...
drug interactions
... Primarily due to displacement of one drug from its binding sites on plasma proteins by another drug. Drugs highly bound to plasma proteins that have a relatively small volume of distribution like oral anticoagulants, sulfonylureas, certain NSAIDs and anti-epileptics are particularly liable to displa ...
... Primarily due to displacement of one drug from its binding sites on plasma proteins by another drug. Drugs highly bound to plasma proteins that have a relatively small volume of distribution like oral anticoagulants, sulfonylureas, certain NSAIDs and anti-epileptics are particularly liable to displa ...
molecular physiology insight in overcoming
... Ethambutol (EMB) (inhibits an arabinosyl transferase and biosynthesis of arabinogalactan of cell wall) ...
... Ethambutol (EMB) (inhibits an arabinosyl transferase and biosynthesis of arabinogalactan of cell wall) ...
Pharmacokinetics - The Cambridge MRCPsych Course
... 10mg / 12hrs 20mg / 24hrs Increasing the dose and increasing the interval Cavss remains the same but fluctuation in Cp is more ...
... 10mg / 12hrs 20mg / 24hrs Increasing the dose and increasing the interval Cavss remains the same but fluctuation in Cp is more ...
Antimycobacterial drugs
... death due to infectious disease. Periods of treatment ( minimum 6 months) Drugs are divided into two groups: First line Second line ...
... death due to infectious disease. Periods of treatment ( minimum 6 months) Drugs are divided into two groups: First line Second line ...
Pharmaceutical Medicinal Chemistry-3
... The first part of the subject deals with drugs used in cancer with main emphasis on alkylating agents, platinum based drugs, antimetabolites, antibiotics, mitotic inhibitors and combination therapy. The second part of the course will concentrate on studying diuretics and respiratory drug development ...
... The first part of the subject deals with drugs used in cancer with main emphasis on alkylating agents, platinum based drugs, antimetabolites, antibiotics, mitotic inhibitors and combination therapy. The second part of the course will concentrate on studying diuretics and respiratory drug development ...
lec.11-426
... acetic acid. Mercuric acetate solution is added and the solution titrated with 0.1 N perchloric acid with methyl orange as indicator. • Spectrophotometrically. • HPLC. ...
... acetic acid. Mercuric acetate solution is added and the solution titrated with 0.1 N perchloric acid with methyl orange as indicator. • Spectrophotometrically. • HPLC. ...
Nonsteroidal Anti-inflammatory Drugs
... • Mainly on liver due to its active metabolite ( N-acetyl-pbenzoquinone). • At therapeutic doses increases hepatic enzymes. • At high doses causes hepatic necrosis & renal necrosis. • Treatment of paracetamol toxicity with N-acetylcystine (SH donor ) as life saving ...
... • Mainly on liver due to its active metabolite ( N-acetyl-pbenzoquinone). • At therapeutic doses increases hepatic enzymes. • At high doses causes hepatic necrosis & renal necrosis. • Treatment of paracetamol toxicity with N-acetylcystine (SH donor ) as life saving ...
Uses
... dose-dependent bone marrow suppression, which occurs if the drug is given for long periods and is reversible when treatment is stopped, an idiosyncratic reaction causing aplastic anemia, this is not dose-dependent and is irreversible. It can occurs after treatment has stopped but is fortunately very ...
... dose-dependent bone marrow suppression, which occurs if the drug is given for long periods and is reversible when treatment is stopped, an idiosyncratic reaction causing aplastic anemia, this is not dose-dependent and is irreversible. It can occurs after treatment has stopped but is fortunately very ...
General Information/How to use this table :
... Table #1: For each of the drugs listed here, it is vital to recognize whether the drug, as taken, is an active drug or a pro-drug that must be metabolized to an active form before having a clinical effect. These pro-drugs are indicated by the entry “(p)” following the name of the drug. If the substa ...
... Table #1: For each of the drugs listed here, it is vital to recognize whether the drug, as taken, is an active drug or a pro-drug that must be metabolized to an active form before having a clinical effect. These pro-drugs are indicated by the entry “(p)” following the name of the drug. If the substa ...
Lecture 10a
... activity will decrease to 25 %, most likely due to the increased polarity of the compound (additional hydrogen bonding) If the nitrogen atom is missing from the structure, the compound displays no activity at all The aromatic ring is important as well because without it the compound is inactive as ...
... activity will decrease to 25 %, most likely due to the increased polarity of the compound (additional hydrogen bonding) If the nitrogen atom is missing from the structure, the compound displays no activity at all The aromatic ring is important as well because without it the compound is inactive as ...
Drugs that increase the INR and risk of bleed Drugs that decrease
... on warfarin. This list is not exhaustive - refer to the British National Formulary (BNF) for further information. If any of the drugs below are to be started in these patients then the use of alternatives in the same therapeutic class may be considered. If this is not possible then the patient’s INR ...
... on warfarin. This list is not exhaustive - refer to the British National Formulary (BNF) for further information. If any of the drugs below are to be started in these patients then the use of alternatives in the same therapeutic class may be considered. If this is not possible then the patient’s INR ...
Chemotherapy
... Used to prevent subacute bacterial endocarditis due to dental extraction or tonsillectomy in patients with congenital or acquired valve disease ...
... Used to prevent subacute bacterial endocarditis due to dental extraction or tonsillectomy in patients with congenital or acquired valve disease ...
on methodological conference
... Glucocorticoids group of drugs that are structural and functional analogs of hormones that are synthesized in zona fasciculata of the adrenal cortex. Pulse-therapy scheme ultrahigh doses of corticosteroids administration for shortterm patients with severe and life threatening diseases or conditions ...
... Glucocorticoids group of drugs that are structural and functional analogs of hormones that are synthesized in zona fasciculata of the adrenal cortex. Pulse-therapy scheme ultrahigh doses of corticosteroids administration for shortterm patients with severe and life threatening diseases or conditions ...
zzz - pharm 1st retake 2010.1 - SAMIT - kasiula264
... Aspirin irreversibly binds fibrinogen, which decreases pool of available fibrin ...
... Aspirin irreversibly binds fibrinogen, which decreases pool of available fibrin ...
Pantothenic Acid - Jacqueline Farralls Portfolio
... There is no specific RDA for Pantothenic acid; however, a daily adequate intake level has been set at 5 mg per day for healthy adults. 3. How is the nutrient metabolized? Pantothenic acid is a water-soluble vitamin, and therefore not stored by the body. However, it is important for our bodies to pro ...
... There is no specific RDA for Pantothenic acid; however, a daily adequate intake level has been set at 5 mg per day for healthy adults. 3. How is the nutrient metabolized? Pantothenic acid is a water-soluble vitamin, and therefore not stored by the body. However, it is important for our bodies to pro ...
Patient Case - Vanderbilt University Medical Center
... multicenter study conducted in 9 centers in Canada – Treatment arm (N=65): Loading dose of MMF 1500mg twice daily until POD 5, then 1000mg twice daily • 61.5% received a PPI – Control arm (N=61): MMF1000mg twice daily • 54.1% received a PPI Kiberd BA, et al. Ther Drug Monit. 2011;33:120-123. ...
... multicenter study conducted in 9 centers in Canada – Treatment arm (N=65): Loading dose of MMF 1500mg twice daily until POD 5, then 1000mg twice daily • 61.5% received a PPI – Control arm (N=61): MMF1000mg twice daily • 54.1% received a PPI Kiberd BA, et al. Ther Drug Monit. 2011;33:120-123. ...
Противомикробни средства
... In some infections the choice of antimicrobails follows automatically from the cliniccal diagnosis because the causative organknish is always the same, and is virtually always sensitive to the same drug, e.g. segmental pneumonia in a young person which is almost always caused by S. pneumonia (benzy ...
... In some infections the choice of antimicrobails follows automatically from the cliniccal diagnosis because the causative organknish is always the same, and is virtually always sensitive to the same drug, e.g. segmental pneumonia in a young person which is almost always caused by S. pneumonia (benzy ...
Reading Material
... • Child bearing potential was narrowly defined as any woman physiologically capable of becoming pregnant, regardless of sexual activity, sexual practices and contraceptive use • In 1990, the NIH directed that women and minorities be included in clinical trials ...
... • Child bearing potential was narrowly defined as any woman physiologically capable of becoming pregnant, regardless of sexual activity, sexual practices and contraceptive use • In 1990, the NIH directed that women and minorities be included in clinical trials ...
Herbal Medicines?: A Case Study
... ‘herbal high’, marketed as a legal alternative to conventional recreational drugs of abuse such as MDMA (‘ecstasy’) and amfetamine, which had been purchased from a local ‘head shop’. She developed nausea and vomiting within 30 minutes of ingestion, followed by a period of ‘dissociative type symptoms ...
... ‘herbal high’, marketed as a legal alternative to conventional recreational drugs of abuse such as MDMA (‘ecstasy’) and amfetamine, which had been purchased from a local ‘head shop’. She developed nausea and vomiting within 30 minutes of ingestion, followed by a period of ‘dissociative type symptoms ...
Adverse effects of antimuscarinic drugs
... - It attaches to the nicotinic receptors and acts like Ach to depolarize the N-M junction. . Initially this produces short-lasting muscle fasciculation, followed within a few minutes by muscle paralysis. does not produce a ganglionic block, except in high doses, although it does have weak histamine- ...
... - It attaches to the nicotinic receptors and acts like Ach to depolarize the N-M junction. . Initially this produces short-lasting muscle fasciculation, followed within a few minutes by muscle paralysis. does not produce a ganglionic block, except in high doses, although it does have weak histamine- ...
Discovery and development of proton pump inhibitors
Proton pump inhibitors (PPIs) block the gastric hydrogen potassium ATPase (H+,K+-ATPase) and inhibit gastric acid secretion. These drugs have emerged as the treatment of choice for acid-related diseases, including gastroesophageal reflux disease (GERD) and peptic ulcer disease.PPIs also can bind to other types of proton pumps such as those that occur in cancer cells and are finding applications in the reduction of cancer cell acid efflux and reduction of chemotherapy drug resistance.